
The Impact of GLP-1–Mediated Weight Loss on Mammographic Density and Radiomic Risk
Julia E. McGuiness, MD, discussed the timeline for mammographic density changes following significant weight loss.
The rapid clinical integration of GLP-1 receptor agonists has introduced new variables into the assessment of long-term breast cancer risk. While the correlation between obesity and malignancy is well-established, the specific radiomic timeline for risk reduction following significant weight loss remains a point of active investigation.
In an interview with CancerNetwork®, Julia E. McGuinness, MD, assistant professor of medicine in the Division of Hematology/Oncology at Columbia University Herbert Irving Medical Center, explored how metabolic interventions influence breast tissue composition. By examining retrospective data from bariatric surgery cohorts, McGuiness highlighted the shift from traditional density measurements to AI-driven quantitative techniques. She explained why a decrease in breast density, occurring as early as 1 to 2 years post-intervention, may serve as an independent indicator of risk reduction, potentially signaling physiological changes that extend beyond a simple shift in body mass index.
Transcript:
A lot of the data that we have comes from when bariatric surgery was one of the main ways to achieve the same or similar degree of weight loss as GLP-1s. What we can see from retrospective studies is that the timing of mammographic changes is often earlier. A lot of the weight loss after bariatric surgery can occur in the first 1 to 2 years after the intervention. We can see such early mammographic changes in terms of the density. One challenge with mammographic density in patients who are overweight or obese is an inverse relationship between body mass index and mammographic density. Obesity leads to an increased proportion of fat in the breast tissue. [This] can be associated with lower breast density, but we know that obesity is a very important risk factor for breast cancer. With quantitative and more AI driven techniques for measuring breast density, we see that, even when patients lose weight where you would expect, their density would increase as the relative proportion of fat decreases. We see a decrease in breast density, signaling that there’s probably something independent of the changes in weight that we’re seeing with breast cancer risk and weight loss. It should be an early indicator as the weight loss occurs.
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.


























































